For example, in breast cancer models the release of EV-associated miR-181c and its entry into endothelial cells downregulates 3-phosphoinositide dependent protein kinase 1 (PDPK1) resulting in disruption of cofilin regulated actin dynamics and local inactivation of BBB. Here, PDPK1 is linked to breast cancer.